Similar Items: Features predicting data exclusion in imaging studies of Alzheimer's disease
- Investigating the amyloid–tau–neurodegeneration framework in Alzheimer's disease using semi‐supervised multimodal imaging data fusion
- Alzheimer's disease drug development pipeline: 2026
- APOE‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
- Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
- Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging